Cargando…
Glucocerebrosidase mutations and Parkinson disease
The discovery of glucocerebrosidase (GBA1) mutations as the greatest numerical genetic risk factor for the development of Parkinson disease (PD) resulted in a paradigm shift within the research landscape. Efforts to elucidate the mechanisms behind GBA1-associated PD have highlighted shared pathways...
Autores principales: | Vieira, Sophia R. L., Schapira, Anthony H. V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463283/ https://www.ncbi.nlm.nih.gov/pubmed/35932311 http://dx.doi.org/10.1007/s00702-022-02531-3 |
Ejemplares similares
-
Association Between Glucocerebrosidase Mutations and Parkinson's Disease in Ireland
por: Olszewska, Diana A., et al.
Publicado: (2020) -
Dermal Phospho-Alpha-Synuclein Deposition in Patients With Parkinson's Disease and Mutation of the Glucocerebrosidase Gene
por: Doppler, Kathrin, et al.
Publicado: (2018) -
Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study
por: David, Fabian J., et al.
Publicado: (2021) -
The relationship between glucocerebrosidase mutations and Parkinson disease
por: Migdalska‐Richards, Anna, et al.
Publicado: (2016) -
Investigation of Somatic Mutations in Human Brains Targeting Genes Associated With Parkinson's Disease
por: Leija-Salazar, Melissa, et al.
Publicado: (2020)